suven life sciences limited · (654.46) (2593.61) (946.84) (1295.65) (10640.08) (4004.57) 4 net...
TRANSCRIPT
CS/NSE&BSE/UFR/2020-21 August 12, 2020
To The General Manager Department of Corporate Services BSE Limited 25th Floor, P. J. Towers, Dalai Street, Mumbai - 400001
Scrip Code: 530239
Dear Sir/Madam,
SUVEN Life Sciences
To The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kuria Complex Bandra (E), Mumbai - 400051
Scrip Symbol: SUVEN
Sub: Newspaper advertisement - Un-audited Financial Results of the Company for quarter ended 30th June, 2020
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding to Un-audited Financial Results of the Company for quarter ended 30th June, 2020. The advertisements are as appeared on 12th August, 2020 in Business Standard and Andhra Prabha (Telugu).
The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx
This is for your information and record.
Thanking you, Yours faithfully, For Suven Life Sciences Limited
Sint'enik Soni Company Secretary
Encl.: as above
Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7
Banjara Hills I Hyderabad — 500 034 I Telangana I India I CI N: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 3311/ 3315 Fax: 91 40 2354 1152 Email: [email protected] website: www.suven.com
Suven Life Sciences Limited Registered Office: 8-2-334 I SDE Serene Chambers I 6th Floor Road No.5 I Avenue 7
Banjara Hills I Hyderabad – 500 034 I Telangana I India I CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142/ 3311/ 3315 Fax: 91 40 2354 1152 Email: [email protected] website: www.suven.com
CS/NSE&BSE/UFR/2020-21 August 12, 2020
To The General Manager Department of Corporate Services BSE Limited 25th Floor, P. J. Towers, Dalal Street, Mumbai - 400001
To The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex Bandra (E), Mumbai – 400051
Scrip Code: 530239 Scrip Symbol: SUVEN
Dear Sir/Madam,
Sub: Newspaper advertisement – Un-audited Financial Results of the Company for quarter ended 30th June, 2020 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisements regarding to Un-audited Financial Results of the Company for quarter ended 30th June, 2020. The advertisements are as appeared on 12th August, 2020 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at: http://www.suven.com/newspaperads.aspx This is for your information and record. Thanking you, Yours faithfully, For Suven Life Sciences Limited Shrenik Soni Company Secretary Encl.: as above
21){5azdo 12 erIKE 2020 Eptsvaim8ls
c o .';.).35 E,7,-) -,,M37.5 e) a)E.35 53.7.96 re•gocQc.: 8-2-334..44m ''',,B ,TosA, tiC soeMi. dili 30.5. e36rg 7. oZ,Q4ned.e.:). 500 034. ason'o, soacer
mZ5 ! .3052411065131989t.V4M009713 CO: 91 40 2954 1142/3311/3315, 0•g5): 91 40 2354 1152.
s-33c.ud: [email protected], WIC: www.suven.com
es 30, 20208 5 6.3381)K1 5,130Mo Sat56.)
e& IScIfotO (3 o8 (5.06$5 tfoOctiv gmapc1.155 eig 4.11)§2Fte) c..3mdaAt.t:Ponlo cr. ° t at
te08 0645 5.6.0416
5. dittllavev
508,54 atatAdo
0»550 getlipo
&IAA ggrago
esNas agoomo
ave,Ist, eceepo
SIAM deseSo
go. 30/06/2020 31/03/2020 30/06/2019 30/06/2020 31/03/2020 30/06/2019
eadSceolso (WS:o aa6 &tam _.,
.546 dm= *SC Zug 68,06 &ISOM
asessicstse 5)08 Buds swabs 142.86 1441.47 159.49 142.86 1441.47 159.49
2 050 onso sway 0,6} teetSous.55/5.6 01080 / 6coeteuven o6 . ......+6S
(654.461 (2593.61) (94684) (1295.65) 110640.08) (400457)
3 0800p0me0811554,8181001a086Uli0800 5?516/8611,188 0019e600400418xamil
k554.461 (2593.61) (946.841 (1295.651 (10640.08) (4004„57)
4 080 eseoswevi gg.1.86.,04 mosacong
aft &ad%) / 6,8 80706ta oboo 0=14) (407.74) (1375.32)
454.43 (1048.93) (9421.791 12603301
5 agtio 88)0,inpod)o sy0ow41 Wool 01450 0,114,663gged) Woo:11)43M Atoaessolo (95.1,,,desewS)
8011 ceuaken
(415.12) (1404.86) 453.74 (1056.31) (9451.33) (2603.99)
6 oazet 0.4/. 0.0.0050 1272.82 127282 1272.82 1272.82 1272.82 1272.82 7 oat 046 (6 sg411tc510 0800 ax11.11)
add ,Sgx1 sp4.84 t4384,W4e,8g. Won. 3749453 13062.02
8 eye owee 0 cam* ,984,,11
Cog .0.32 -1.08 0,36 -0.82 -7.40 -2.05
E0,365 .0.32 .1.08 0.36 -0.82 .7.40 .2.05
(04soo,uoroo) (a.tec000gro) (0.40ft.."4.2.ta taVcoda.4011) 0,00o...126914 4S,4[..loaDSO
(751(09: E8 600000 Le (0 Soe,13o5 Olv 860 50986 83515,3x6,,) 864560,2015 ciSus, Ses,154,6 33 itoe,* ecode.91 easev,as depu n. 908.0 as., .43.0 ....... a..., Aeovolo. attusSIS eta 0044•0 eaves 83.0 *Sows * e4lot9 ou SueeSu 09.5 ,0618 07114,, Zek.Alev
(www.bseindia.com Waal» www nseind ia . corm wpm%) 9o80 cessie 3k045www.suven.com (vo61us4c468 tivku.
.13,5 gi PA 0.7.11315 8008) ZoStS 80
gsieo:tvecoess8 .045 & W.,
So: 11 e311.1, 2020 50088:00278028
•
Business Standard HYDERABAD [ WEDNESDAY, 12 AUGUST 2020 5
SUVEN LIFE SCIENCES LIMITED Regd Office: 8-2-334, SDE Serene Chambers, 6th Floor, Road No. 5, Avenue 7, Banjara Hills, 500 034, Telangana, India.
CIN: L24110TG1989PLC009713 Tel: 91 40 2354 1142 / 3311 / 3315 Fax: 91 40 2354 1152 Email: [email protected] Website: www.suven.com
EXTRACT OF UN-AUDITED STANDALONE & CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2020
(2' in Lakhs
SI. No. Particulars
STANDALONE CONSOLIDATED
Quarter Ended
30/06/2020
Year Ended
31/03/2020
Quarter Ended
30/06/2019
Quarter Ended
30/06/2020
Year Ended
31/03/2020
Quarter Ended
30/06/2019
Un-audited Audited Un-audited Un-audited Audited Un-audited
1 Total income from operations 142.86 1441.47 159.49 142.86 1441.47 159.49
2 Net profit for the period (before tax, exceptional and / or extraordinary items)
(654.46) (2593.61) (946.84) (1295.65) (10640.08) (4004.57)
3 Net profit for the period before tax (after exceptional and / or extraordinary items)
(654.46) (2593.61) (946.84) (1295.65) (10640.08) (4004.57)
4 Net profit for the period After tax (after exceptional and / or extraordinary items)
(407.74) (1375.32) 454.43 (1048.93) (9421.79) (2603.30)
5 Total comprehensive income for the period [comprising profit for the period (after tax) and other comprehensive income (after tax)
(415,12) (1404.86) 453.74 (1056.31): (9451.33) (2603.99)
6 Equity share capital 1272.82 1272.82 1272.82 1272.82 1272.82 1272.82 7 Other Equity (Exduding Revaluation Reserve)
as shown in the audited balance sheet 37494.53 13062.02
8 Earnings Per Share (of Rs.1.00/- each)
1. Basic -0.32 -1.08 0.36 -0.82 -7.40 -2.05
2. Diluted -0.32 -1.08 0.36 -0.82 -7A0 -2.05
(not annualised) (not annualised) (not annualised) (not annualised) (not annualised) (not annualised)
Notes: The above is an extract of the detailed format of Quarterly Financial Results filed with the Stock Exchanges under Regulation 33 of the SEB (Listing and Other Disclosure Requirements) Regulations, 2015. The full format of the Quarterly Financial Results are available on the websites of the stock exchanges(s) and the listed entity. (www.bseindia.com and www.nseindia.com) and company's website www.suven.com.
For SUVEN LIFE SCIENCES LTD VENKAT JASTI Chairman & CEO DIN: 00278028
Place: Hyderabad Date : 11th, August 2020